tiprankstipranks
FibroGen reports Q4 EPS 18c, consensus (20c)
PremiumThe FlyFibroGen reports Q4 EPS 18c, consensus (20c)
10d ago
FibroGen options imply 18.1% move in share price post-earnings
Premium
The Fly
FibroGen options imply 18.1% move in share price post-earnings
10d ago
Options Volatility and Implied Earnings Moves Today, March 17, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 17, 2025
11d ago
FibroGen Sells Subsidiary to AstraZeneca for $160M
PremiumCompany AnnouncementsFibroGen Sells Subsidiary to AstraZeneca for $160M
1M ago
FibroGen selling FibroGen China to AstraZeneca for $160M
Premium
The Fly
FibroGen selling FibroGen China to AstraZeneca for $160M
1M ago
Perspective Therapeutics appoints Graham as CFO
Premium
The Fly
Perspective Therapeutics appoints Graham as CFO
3M ago
FibroGen Reports Strong Q3 Growth and Future Plans
PremiumCompany AnnouncementsFibroGen Reports Strong Q3 Growth and Future Plans
5M ago
FGEN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
FGEN Upcoming Earnings Report: What to Expect?
5M ago
Disc Medicine appoints Kaushik as Chief Technical Officer
Premium
The Fly
Disc Medicine appoints Kaushik as Chief Technical Officer
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100